BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26782711)

  • 1. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
    Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
    BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis.
    Tan P; Wei S; Yang L; Tang Z; Cao D; Liu L; Lei J; Fan Y; Gao L; Wei Q
    Sci Rep; 2016 Jul; 6():29106. PubMed ID: 27384548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies.
    Scosyrev E; Tobis S; Donsky H; Wu G; Joseph J; Rashid H; Messing E
    BJU Int; 2013 Mar; 111(3 Pt B):E71-7. PubMed ID: 23017100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies.
    Sun JX; Liu CQ; Zhong XY; Xu JZ; An Y; Xu MY; Hu J; Zhang ZB; Xia QD; Wang SG
    Front Oncol; 2022; 12():887854. PubMed ID: 35615153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
    Larsen SB; Dehlendorff C; Skriver C; Dalton SO; Jespersen CG; Borre M; Brasso K; Nørgaard M; Johansen C; Sørensen HT; Hallas J; Friis S
    J Clin Oncol; 2017 Oct; 35(29):3290-3297. PubMed ID: 28806117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.
    Danzig MR; Kotamarti S; Ghandour RA; Rothberg MB; Dubow BP; Benson MC; Badani KK; McKiernan JM
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):63-8. PubMed ID: 25403419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
    Rieken M; Kluth LA; Xylinas E; Seitz C; Fajkovic H; Karakiewicz PI; Lotan Y; Briganti A; Loidl W; Faison T; Crivelli JJ; Scherr DS; Bachmann A; Tewari AK; Kautzky-Willer A; Pummer K; Shariat SF
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):367-71. PubMed ID: 23999669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and risk of disease recurrence and death after radical prostatectomy.
    Keskiväli T; Kujala P; Visakorpi T; Tammela TL; Murtola TJ
    Prostate; 2016 Apr; 76(5):469-78. PubMed ID: 26689439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.
    Lyon TD; Turner RM; Yabes JG; Woldemichael E; Davies BJ; Jacobs BL; Nelson JB
    Urology; 2016 Nov; 97():153-159. PubMed ID: 27516122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.
    Mass AY; Agalliu I; Laze J; Lepor H
    J Urol; 2012 Sep; 188(3):786-91. PubMed ID: 22818136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
    Bonovas S; Filioussi K; Sitaras NM
    Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of statin for cancer patients: 
A Meta-analysis.
    Li Y; Li Y; Lei X; Liu L; Zhang D; Tang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):770-81. PubMed ID: 26267691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis.
    Foerster B; Pozo C; Abufaraj M; Mari A; Kimura S; D'Andrea D; John H; Shariat SF
    JAMA Oncol; 2018 Jul; 4(7):953-961. PubMed ID: 29800115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
    Harshman LC; Wang X; Nakabayashi M; Xie W; Valenca L; Werner L; Yu Y; Kantoff AM; Sweeney CJ; Mucci LA; Pomerantz M; Lee GS; Kantoff PW
    JAMA Oncol; 2015 Jul; 1(4):495-504. PubMed ID: 26181260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis.
    Jayalath VH; Clark R; Lajkosz K; Fazelzad R; Fleshner NE; Klotz LH; Hamilton RJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242676. PubMed ID: 36449294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.